Stock Scorer

Burning Rock Biotech Ltd (BNR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Annual

0 30M 60M 90M FY21: 79.7M FY22: 81.7M FY23: 75.7M FY24: 70.7M FY25: 77.2M FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 20M 40M 60M FY21: 57.1M FY22: 55.1M FY23: 51.2M FY24: 49.6M FY25: 57.6M FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-150M -100M -50M 0 50M 100M 150M FY21: -125.1M FY22: -142.1M FY23: -94.3M FY24: -49M FY25: -7.8M FY21 FY22 FY23 FY24 FY25

Net Income Annual

-150M -100M -50M 0 50M 100M 150M FY21: -125M FY22: -140.8M FY23: -92.1M FY24: -47.5M FY25: -7.9M FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 10M 20M 30M FY21: 22.6M FY22: 26.6M FY23: 24.5M FY24: 21M FY25: 19.5M FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-90M -60M -30M 0 30M 60M 90M FY21: -75M FY22: -66.2M FY23: -36M FY24: -12.6M FY25: -4.1M FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-120M -80M -40M 0 40M 80M 120M FY21: -107.1M FY22: -75.2M FY23: -37.2M FY24: -13.4M FY25: -4.8M FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

EPS Annual

0.00 FY20: 0.00 FY21: 0.00 FY20 FY21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for BNR: Shares Outstanding. Nothing in this filer's XBRL supports it for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.